Ticker Scorecard - MRK Basics Company: Merck & Co., Inc. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Activated in VL: True Average Daily Range Avg Daily Range: $0.50 | 0.88% Avg Daily Range (30 D): $1.04 | 1.14% Avg Daily Range (90 D): $0.99 | 1.01% Institutional Daily Volume Avg Daily Volume: 10.57M Avg Daily Volume (30 D): 12.79M Avg Daily Volume (90 D): 9.44M Trade Size Avg Trade Size (Sh.): 181 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 163,819 Avg Inst. Trade: $5.32M Avg Inst. Trade (30 D): $11.67M Avg Inst. Trade (90 D): $13.29M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 30 Market Closing Trades Avg Closing Trade: $83.26M Avg Closing Trade (30 D): $206.24M Avg Closing Trade (90 D): $211.56M Avg Closing Volume: 1.13M     News Feb 21, 2025 @ 3:00 PM Hyperlipidemia Drugs Market Size to Promote USD 31... Source: Towards Healthcare Feb 20, 2025 @ 9:50 PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck ... Source: N/A Feb 20, 2025 @ 6:00 PM BESREMi Achieves Strong Market Growth Amid Rising ... Source: Delveinsight Feb 20, 2025 @ 6:00 PM Antibody-Drug Conjugates Market to Witness Rapid G... Source: Delveinsight Feb 20, 2025 @ 1:45 AM North America Leads the Beta-Glucan Boom: Market I... Source: Globe Newswire Financials   TTM Q3 2024 Q2 2024 Basic EPS $4.79 $1.25 $2.15 Diluted EPS $4.78 $1.24 $2.14 Revenue $ 63.17B $ 16.66B $ 16.11B Gross Profit $ 47.9B $ 12.58B $ 12.37B Net Income / Loss $ 12.16B $ 3.16B $ 5.46B Operating Income / Loss $ 13.72B $ 4.09B $ 6.01B Cost of Revenue $ 15.28B $ 4.08B $ 3.75B Net Cash Flow $ 6.02B $ 3.32B $ 5.7B PE Ratio 18.69